Abstract
Cytostatic drugs and other pharmaceuticals are newly recognized classes of environmental pollutants that receive considerable attention because of their categorization as carcinogenic, mutagenic, and teratogenic compounds. Although the cytostatics belong to currently unregulated trace-level contaminants, this situation can change in the near future. Due to poor biodegradability and low removal efficiency by conventional wastewater treatments, the alternative methods for a successful elimination of these drugs have been developed and investigated. This chapter provides a review of recent scientific research on the elimination of cytostatic drugs from water and wastewater by advanced physicochemical, chemical and biological methods, and advanced oxidation processes. The advanced treatments including membrane filtration, adsorption, ozonation, biomembrane filtration and advanced oxidation processes (AOPs), such as the Fenton reaction, photodegradation under solar and UV irradiation, and electrochemical oxidation, constitute a promising technology for the treatment of water and wastewater containing cytostatic drugs. In the presented review, data published on the degradation of cytostatic drugs by the aforementioned alternative methods have been evaluated for the period 2007–2017. Additional aspects of the problem such as the operating conditions, influence of the aqueous matrix quality on the removal efficacy, decomposition mechanism of cytostatic drugs based on the identified intermediates, and the advantages and disadvantages of the applied processes are also discussed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Agenson KO, Urase T (2007) Change in membrane performance due to organic fouling in nanofiltration (NF)/reverse osmosis (RO) applications. Sep Purif Technol 55(2):147–156
Akalin E, Akyuz S, Akyuz T (2007) Adsorption and interaction of 5-Xuorouracil with montmorillonite and saponite by FT-IR spectroscopy. J Mol Struct 834–836:477–481
Barek J, Cvacka J, Zima J, Meot MDE, Lagett M, Michelon J, Castegnarot M (1998) Chemical degradation of wastes of antineoplastic agents Amsacrine, azathioprine, Asparaginase and Thiotepa. Ann Occup Hyg 42:259–266
Barisci S, Dimoglo A (2016) Chapter 12: Review on the stability of ferrate (VI) species in aqueous medium and oxidation of Pharmaceuticals and Personal Care Products (PPCPs) by ferrate (VI): identification of transformation by-products. In: Ferrites and ferrates: chemistry and applications in sustainable energy and environmental remediation. American Chemical Society, pp 287–335. https://doi.org/10.1021/bk-2016-1238.ch012
Barisci S, Turkay O, Ulusoy E, Dimoglo A (2015) Degradation of the cytostatic methotrexate by electrosynthesized ferrate (VI): identification of oxidation by-products. Conference paper, https://www.researchgate.net/publication/288416292
Bellona C, Drewes JE (2007) Viability of a low-pressure nanofilter in treating recycled water for water reuse applications: a pilot-scale study. Water Res 41(17):3948–3958
Bellona C, Drewes JE, Xu P, Amy G (2004) Factors affecting the rejection of organic solutes during NF/RO treatment—a literature review. Water Res 38(12):2795–2809
Bernhard M, Müller J, Knepper TP (2006) Biodegradation of persistent polar pollutants in wastewater: comparison of an optimised lab-scale membrane bioreactor and activated sludge treatment. Water Res 40:3419–3428
Besse JP, Latour JF, Garric J (2012) Anticancer drugs in surf waters: what can we say about the occurrence and environmental significance of cytotoxic, cytostatic and endocrine therapy drugs. Environ Int 39:73–86
Bielski BHJ (1991) Studies of hypervalent iron. Free Radic Res Commun 12:469–477
Brillas E, Sires I (2015) Electrochemical removal of pharmaceuticals from water streams: reactivity elucidation by mass spectrometry. Trends Anal Chem 70:112–121
Česen M, Kosjek T, Laimou-Geraniou M, Kompare B, Širok B, Lambropolou D, Heath E (2015) Occurrence of cyclophosphamide and ifosfamide in aqueous environment and their removal by biological and abiotic wastewater treatment processes. Sci Total Environ 527–528:465–473
Chen Z, Park G, Herckes P, Westerhoff P (2008) Physicochemical treatment of three chemotherapy drugs: irinotecan, tamoxifen, and cyclophosphamide. J Adv Oxid Technol 11:254–260
Clara M, Strenn B, Gans O, Martinez E, Kreuzinger N, Kroiss H (2005) Removal of selected pharmaceuticals, fragrances and endocrine disrupting compounds in a membrane bioreactor and conventional wastewater treatment plants. Water Res 39:4797–4807
Cui L, Wang Y, Niu M, Chen G, Cheng Y (2009) Synthesis and visible light photocatalysis of Fe-doped TiO2 mesoporous layer deposited on hollow glass microbeads. J Solid Sate Chem 182:2785–2790
de la Cruz N, Giménez J, Esplugas S, Grandjean D, de Alencastro LF, Pulgarín C (2012) Degradation of 32 emergent contaminants by UV and neutral photo-Fenton in domestic wastewater effluent previously treated by activated sludge. Water Res 46:1947–1957
de Wever H, Weiss S, Reemtsma T, Vereecken J, Müller J, Knepper T, Rörden O, Gonzalez S, Barcelo D, Hernando MD (2007) Comparison of sulfonated and other micropollutants removal in membrane bioreactor and conventional wastewater treatment. Water Res 41(4):935–945
Delgado LF, Dorandeu C, Marion B, Gonzalez C, Faucet-Marquis V, Schetrite S, Albasi C (2009) Removal of a cytostatic drug by a membrane bioreactor. Desalin Water Treat 9(1–3):112–118
Delgado LF, Faucet-Marquis V, Schetrite S, Pfohl-Leszkowicz A, Paranthoen S, Albasi C (2010) Effect of cytostatic drugs on the sludge and on the mixed liquor characteristics of a cross-flow membrane bioreactor: consequence on the process. J Membr Sci 347:165–173
Delgado LF, Faucet-Marquis V, Pfohl-Leszkowicz A, Dorandeu C, Marion B, Schetrite S, Albasi C (2011) Cytotoxicity micropollutant removal in a crossflow membrane bioreactor. Bioresour Technol 102:4395–4401
Dodd MC, Zuleeg S, von Gunten U, Pronk W (2008) Ozonation of source-separated urine for resource recovery and waste minimization: process modeling, reaction chemistry, and operational considerations. Ozonation source separated urine resource. Recovery waste minimization process model. React Chem Oper Consider 42:9329–9337
Escher BI, Pronk W, Suter MJF, Maurer M (2006) Monitoring the removal efficiency of pharmaceuticals and hormones in different treatment processes of source-separated urine with bioassays. Environ Sci Technol 40:5095–5101
Fabiańska A, Białk-Bielińska A, Stepnowski P, Stolte S, Siedlecka EM (2014) Electrochemical degradation of sulfonamides at BDD electrode: kinetics, reaction pathway and eco-toxicity evaluation. J Hazard Mater 280:579–587
Fabiańska A, Ofiarska A, Fiszka-Borzyszkowska A, Stepnowski P, Siedlecka EM (2015) Electrodegradation of ifosfamide and cyclophosphamide at BDD electrode: decomposition pathway and its kinetics. Chem Eng J 276:274–282
Feng L, van Hullebusch ED, Rodrigo MA, Esposito G, Oturan MA (2013) Removal of residual anti-inflammatory and analgesic pharmaceuticals from aqueous systems by electrochemical advanced oxidation processes. A review. Chem Eng J 228:944–964
Ferre-Aracil J, Valcárcel Y, Negreira N, de Alda ML, Barceló D, Cardona SC, Navarro-Laboulais J (2016) Ozonation of hospital raw wastewaters for cytostatic compounds removal. Kinetic modelling and economic assessment of the process. Sci Total Environ 556:70–79
Fiszka Borzyszkowska A, Pieczyńska A, Ofiarska A, Nikiforow K, Stepnowski P, Siedlecka EM (2016) Bi-B-TiO2-based photocatalytic decomposition of cytostatic drugs under simulated sunlight treatments. Sep Purif Technol 169:113–120
Franquet-Griell H, Gómez-Canela C, Ventura F, Lacorte S (2015) Predicting concentrations of cytostatic drugs in sewage effluents and surface waters of Catalonia (NE Spain). Environ Res 138:161–172
Ganzenko O, Oturan N, Sires I, Huguenot D, van Hullebusch ED, Esposito G, Oturan MA (2017) Fast and complete removal of the 5-fluorouracil drug from water by electro-Fenton oxidation. Environ Chem Lett. https://doi.org/10.1007/s10311-017-0659-6
Garcia-Ac A, Broséus R, Vincent S, Barbeau B, Prévost M, Sauvé S (2010) Oxidation kinetics of cyclophosphamide and methotrexate by ozone in drinking water. Chemosphere 79:1056–1063
Governo M, Santos MSF, Alves A, Madeira LM (2017) Degradation of the cytostatic 5-fluorouracil in water by Fenton and photoassisted oxidation processes. Environ Sci Pollut Res 24:844–854
Hafez HS (2009) Synthesis of highly-acitve single-crystalline TiO2 nanorods and its application in environmental photocatalysis. Mater Lett 63:1471–1474
Hansel S, Castegnaro M, Sportouch MH, De Meo M, Milhavet JC, Laget M, Dumenil G (1997) Chemical degradation of wastes of antineoplastic agents: cyclophosphamide, ifosfamide and melphalan. Int Arch Occup Environ Health 69:109–114
Helbling DE, Johnson DR, Honti M, Fenner K (2012) Micropollutant biotransformation kinetics associate with WWTP process parameters and microbial community characteristics. Environ Sci Technol 46:10579–10588
Hernández C, Ramos Y, Fernández LA, Ledea O (2008) Ozonation of cisplatin in aqueous solution at pH 9. Ozone Sci Eng 30:189–196
Hirose J, Kondo F, Nakano T, Kobayashi T, Hiro N, Ando Y, Sano K (2005) Inactivation of antineoplastics in clinical wastewater by electrolysis. Chemosphere 60:1018–1024
Hok L, Ulm L, Tandari T, Krivohlavek A, Šakič D, Vrček V (2018) Chlorination of 5-fluorouracil: reaction mechanism and ecotoxicity assessment of chlorinated products. Chemosphere 207:612–619
Ide Y, Koike Y, Ogawa M (2011) Molecular selective photocatalysis by TiO2/nanoporous silica core/shell particulates. J Colloid Interface Sci 358(1):245–251
Johnson AC, Jurgens MD, Williams RJ, Kummerer K, Kortenkamp A, Sumpter JP (2008) Do cytotoxic chemotherapy drugs discharged into rivers pose a risk to the environment and human health ? An overview and UK case study. J Hydrol 44:167–175
Judd SJ (2004) A review of fouling of membrane bioreactors in sewage treatment. Water Sci Technol 49(2):229–235
Judd SJ (2008) The status of membrane bioreactor technology. Trends Biotechnol 26(2):109–112
Kazner C, Lehnberg K, Kovalova L, Wintgens T, Melin T, Hollender J, Dott W (2008) Removal of endocrine disruptors and cytostatics from effluent by Nanofiltration in combination with adsorption on powdered activated carbon, 5-th IWA leading-edge Conference on Water and Wastewater Technologies , 1–4 June 2008 Zurich, Switzerland
Kim I, Yamashita N, Tanaka H (2009) Chemosphere Photodegradation of pharmaceuticals and personal care products during UV and UV/H2O2 treatments. Chemosphere 77:518–525
Kimura K, Amy G, Drewes JE, Heberer T, Kim TU, Watanabe Y (2003) Rejection of organic micropollutants (disinfection by-products, endocrine disrupting compounds, and pharmaceutically active compounds) by NF/RO membranes. J Membr Sci 227:113–121
Kiso Y, Sugiura Y, Kitao T, Nishimura K (2001) Effects of hydrophobicity and molecular size on rejection of aromatic pesticides with nanofiltration membranes. J Membr Sci 192(1):1–10
Klavarioti M, Mantzavinos D, Kassinos D (2009) Removal of residual pharmaceuticals from aqueous systems by advanced oxidation processes. Environ Int 35:402–417
Kobayashi T, Hirose J, Sano K, Hiro N, Ijiri Y, Takiuchi H, Nakano T (2008) Evaluation of an electrolysis apparatus for inactivating antineoplastics in clinical wastewater. Chemosphere 72:659–665
Köhler C, Venditti S, Igos E, Klepiszewski K, Benetto E, Cornelissen A (2012) Elimination of pharmaceutical residues in biologically pre-treated hospital wastewater using advanced UV irradiation technology: a comparative assessment. J Hazard Mater 239–240:70–77
Koltsakidou A, Antonopoulou M, Sykiotou M, Evgenidou E, Konstantinou I, Lambropoulou DA (2017) Photo-Fenton and Fenton-like processes for the treatment of the antineoplastic drug 5-fluorouracil under simulated solar irradiation. Environ Sci Pollut Res 24:4791–4800
Kosjek T, Heath E (2011) Occurrence, fate and determination of cytostatic pharmaceuticals in the environment. Trends Anal Chem 30:1065–1087
Kovalova L, Siegrist H, von Gunten U, Eugster J, Hagenbuch M, Wittmer A, Moser R, McArdell CS (2013) Elimination of micropollutants during post-treatment of hospital wastewater with powdered activated carbon, ozone, and UV. Environ Sci Technol 47(14):7899–7908
Lai WW-P, Lin HH-H, Lin AY-C (2015) TiO2 photocatalytic degradation and transformation of oxazaphosphorine drugs in an aqueous environment. J Hazard Mater 287C:133–141
Larsen TA, Lienert J, Joss A, Siegrist H (2004) How to avoid pharmaceuticals in the aquatic environment. J Biotechnol 113:295–304
Lenz K, Mahnik SN, Weissenbacher N, Mader RM, Krenn P, Hann S, Koellensperger G, Uhl M, Knasmu¨ lS, Ferk F, Bursch W, Fuerhacker M (2007) Monitoring, removal and risk assessment of cytostatic drugs in hospital wastewater. Water Sci Technol 56:141–149
Lester Y, Avisar D, Gozlan I, Mamane H (2011) Removal of pharmaceuticals using combination of UV/H2O2/O3 advanced oxidation process. Water Sci Technol J Int Assoc Water Pollut Res 64:2230–2238
Li W, Tanumihardj J, Masuyama T, Korshin G (2015) Examination of the kinetics of degradation of the antineoplastic drug 5-fluorouracil by chlorine and bromine. J Hazard Mater 282:125–132
Li W, Nanaboina V, Chen F, Korshin GV (2016) Removal of polycyclic synthetic musks and antineoplastic drugs in ozonated wastewater: quantitation based on the data of differential spectroscopy. J Hazard Mater 304:242–250
Lin HH-H, Lin AY-C (2014) Photocatalytic oxidation of 5-fluorouracil and cyclophosphamide via UV/TiO2 in an aqueous environment. Water Res 48:559–568
Lin AY-C, Hsueh JH-F, Hong PKA (2015) Removal of antineoplastic drugs cyclophosphamide, ifosfamide, and 5-fluorouracil and a vasodilator drug pentoxifylline from wastewaters by ozonation. Environ Sci Pollut Res 22:508–515
Lutterbeck CA, Baginska E, Machado EL, Kümmerer K (2015a) Removal of the anti-cancer drug methotrexate from water by advanced oxidation processes: aerobic biodegradation and toxicity studies after treatment. Chemosphere 141:290–296
Lutterbeck CA, Machado EL, Kümmerer K (2015b) Photodegradation of the antineoplastic cyclophosphamide: a comparative study of the efficiencies of UV/H2O2, UV/Fe2+/H2O2 and UV/TiO2 processes. Chemosphere 120:538–546
Lutterbeck CA, Wilde ML, Baginska E, Leder C, Machado EL, Kümmerer K (2015c) Degradation of 5-FU by means of advanced (photo)oxidation processes: UV/H2O2, UV/Fe2+/H2O2 and UV/TiO2 – comparison of transformation products, ready biodegradability and toxicity. Sci Total Environ 527–528:232–245
Mahnik SN, Lenz K, Weissenbacher N, Mader RM, Fuerhacker M (2007) Fate of 5-fluorouracil, doxorubicin, epirubicin, and daunorubicin in hospital wastewater and their elimination by activated sludge and treatment in a membrane-bio-reactor system. Chemosphere 66(1):30–37
Negreira N, Regueiro J, Lopez de Alda M, Barcelo D (2015) Transformation of tamoxifen and its major metabolites during water chlorination: identification and in silico toxicity assessment of their disinfection byproducts. Water Res 85:199–207
Nghiem LD, Schäfer AI, Elimelech M (2004) Removal of natural hormones by nanofiltration membranes: measurement, modeling, and mechanisms. Environ Sci Technol 38:1888–1896
Nghiem LD, Schafer AI, Elimelech M (2005) Pharmaceutical retention mechanisms by nanofiltration membranes. Environ Sci Technol 39(19):7698–7705
Ofiarska A, Pieczyńska A, Fiszka Borzyszkowska A, Stepnowski P, Siedlecka EM (2016) Pt–TiO2-assisted photocatalytic degradation of the cytostatic drugs ifosfamide and cyclophosphamide under artificial sunlight. Chem Eng J 285:417–427
Quintana J, Weiss S, Reemtsma T (2005) Pathways and metabolites of microbial degradation of selected acidic pharmaceutical and their occurrence in municipal wastewater treated by a membrane bioreactor. Water Res 39:1664–2654
Radjenović J, Petrović M, Ventura F, Barceló D (2008) Rejection of pharmaceuticals in nanofiltration and reverse osmosis membrane drinking water treatment. Water Res 42(14):3601–3361
Roig B, Marquenet B, Delpla I, Bessonneau V, Sellier A, Leder C, Thomas O, Bolek R, Kummerer K (2014) Monitoring of methotrexate chlorination in water. Water Res 57:67–75
Rush JD, Bielski BHJ (1986) Pulse radiolysis studies of alkaline Fe(III) and Fe(VI) solutions. Observation of transient ion complexes with intermediate oxidation states. Am Chem Soc 108:523–525
Seiraa J, Sablayrolles C, Montréjaud-Vignoles M, Albasi C, Joannis-Cassan C (2016) Elimination of an anticancer drug (cyclophosphamide) by amembrane bioreactor: comprehensive study of mechanismsJordan. Biochem Eng J 114:155–163
Somensi CA, Simionatto EL, Dalmarco JB, Gaspareto P, Radetski CMA (2012) A comparison between ozonolysis and sonolysis/ozonolysis treatments for the degradation of the cytostatic drugs methotrexate and doxorubicin: kinetic and efficiency approaches. J Environ Sci Health A Tox Hazard Subst Environ Eng 47:1543–1550
Stieber M, Putschew A, Jekel M (2011) Treatment of pharmaceuticals and diagnostic agents using zero-Valent Iron – kinetic studies and assessment of transformation products assay. Environ Sci Technol 45:4944–4950
Tadkaew N, Sivakumar M, Khan SJ, McDonald JA, Nghiem LD (2010) Effect of mixed liquor pH on the removal of trace organic contaminants in a membrane bioreactor. Bioresour Technol 101(5):1494–1500
Tanumihardj J (2013) Examination of the degradation of the antineoplastic drug 5-fluorouracil by chlorine at varying treatment conditions. Msc thesis, University of Washington
Ternes TA, Joss A, Siegrist H (2004) Scrutinizing pharmaceuticals and personal care products in wastewater treatment. Environ Sci Technol 38(20):392A–399A
Tran NH, Urase T, Ngo HH, Hu J, Ong SL (2013) Insight into metabolic and co-metabolic activities of autotrophic and heterotrophic microorganisms in the biodegradation of emerging trace organic contaminants. Bioresour Technol 146:721–731
Urase T, Kagawa C, Kikuta T (2005) Factors affecting removal of pharmaceutical substances and estrogens in membrane separation bioreactors. Desalination 178(1–3):107–113
Verlicchi P, Al Aukidy M, Zambello E (2015) What have we learned from worldwide experiences on the management and treatment of hospital effluent? – an overview and a discussion on perspectives. Sci Total Environ 514:467–491
Verliefde A, Cornelissen E, Amy G, Van der Bruggen B, van Dijk H (2007a) Priority organic micropollutants in water sources in Flanders and the Netherlands and assessment of removal possibilities with nanofiltration. Environ Pollut 146(1):281–289
Verliefde ARD, Heijman SGJ, Cornelissen ER, Amy G, Van der Bruggen B, van Dijk JC (2007b) Influence of electrostatic interactions on the rejection with NF and assessment of the removal efficiency during NF/GAC treatment of pharmaceutically active compounds in surface water. Water Res 41(15):3227–3240
Verliefde ARD, Cornelissen ER, Heijman SGJ, Verberk JQJC, Amy GL, Van der Bruggen B, van Dijk JC (2008) The role of electrostatic interactions on the rejection of organic solutes in aqueous solutions with nanofiltration. J Membr Sci 322(1):52–66
Verliefde ARD, Cornelissen ER, Heijman SGJ, Petrinic I, Luxbacher T, Amy GL, Van der Bruggen B, van Dijk JC (2009) Influence of membrane fouling by (pretreated) surface water on rejection of pharmaceutically active compounds (PhACs) by nanofiltration membranes. J Membr Sci 330(1–2):90–103
von Gunten U (2003) Ozonation of drinking water: part I. Oxidation kinetics and product formation. Water Res 37(7):1443–1467
Wang L, Albasi C, Faucet-Marquis V, Pfohl-Leszkowicz A, Dorandeu C, Marion B, Causserand C (2009) Cyclophosphamide removal from water by nanofiltration and reverse osmosis membrane. Water Res 43(17):4115–4122
Weiss S, Reemtsma T (2008) Membrane bioreactors for municipal wastewater treatment—a viable option to reduce the amount of polar pollutants discharged into surface waters? Water Res 42:3837–3847
Weissbrodt D, Kovalova L, Ort C, Pazhepurackel V, Moser R, Hollender J, Siegrist H, McArdell CS (2009) Mass flows of X-ray contrast media and cytostatics in hospital wastewater. Environ Sci Technol 43:4810–4817
Westerhoff P, Yoon Y, Snyder S, Wert E (2005) Fate of endocrine-disruptor, pharmaceutical, and personal care product chemicals during simulated drinking water treatment processes. Environ Sci Technol 39:6649–6663
Wu R-J, Chen C-C, Lu C-S, Hsu P-Y, Chen M-H (2010) Phorate degradation by TiO2 photocatalysis: parameter and reaction pathway investigations. Desalination 250:869–875
Yangali-Quintanilla V, Sadmani A, McConville M, Kennedy M, Amy G (2009) Rejection of pharmaceutically active compounds and endocrine disrupting compounds by clean and fouled nanofiltration membranes. Water Res 43(9):2349–2362
Yoon Y, Westerhoff SA, Snyder EC, Wert J, Yoon J (2007) Removal of endocrine disrupting compounds and pharmaceuticals by nanofiltration and ultrafiltration membranes. Desalination 202(1–3):16–23
Zhang C, Gu L, Lin Y, Wang Y, Fu D, Gu Z (2009) Degradation of X-3B dye by immobilized TiO2 photocatalysis coupling anodic oxidation on BDD electrode. J Photochem Photobiol A Chem 207:66–72
Zhang X, Wu F, Deng N (2010) Degradation of paracetamol in self assembly β-cyclodextrin/TiO2 suspension under visible irradiation. Catal Commun 11:422–425
Zhang J, Chang VWC, Giannis A, Wang J-Y (2013) Removal of cytostatic drugs from aquatic environment: a review. Sci Total Environ 445–446:281–298
Acknowledgment
The authors would like to acknowledge the financial support of the Polish Ministry of Research and Higher Education, Poland under the Grant DS530-8626-D596-18.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Siedlecka, E.M. (2020). Removal of Cytostatic Drugs from Water and Wastewater: Progress in the Development of Advanced Treatment Methods. In: Heath, E., Isidori, M., Kosjek, T., Filipič, M. (eds) Fate and Effects of Anticancer Drugs in the Environment. Springer, Cham. https://doi.org/10.1007/978-3-030-21048-9_9
Download citation
DOI: https://doi.org/10.1007/978-3-030-21048-9_9
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-21047-2
Online ISBN: 978-3-030-21048-9
eBook Packages: Earth and Environmental ScienceEarth and Environmental Science (R0)